WoLF PSORT: Protein localization predictor
Emerging evidence suggests that ALC levels are reduced in individuals with MDD, and this deficiency may contribute to depressive symptoms through disruptions in mitochondrial fatty acid transport, neuroplasticity, and neurotransmission
And everyone in the study had diabetes, so no one was taking these medications solely for weight loss
On phase: up to 3 months of active dosing, following the Month 1 to Month 3 titration
And what Im seeing right now in the GLP-1 peptide space is a flood of misinformation, half-truths, and dangerous assumptions based on Reddit threads instead of actual clinical trial data
In general, the drugs get the green light for women with a body mass index (BMI) of 30 or higher, or for those with a BMI of 25 to 29.9 with certain coexisting conditions (like high blood pressure or diabetes)